DUBLIN, October 24, 2017 /PRNewswire/ --

The "Global Precision Medicine Market" report has been added to Research and Markets' offering.

This study includes an overview and analysis of the precision medicine market by ecosystem, sub-markets, therapeutics and geographical regions, allowing the research to develop a comprehensive outlook of the market. The precision medicine market report presents detailed analysis of the entire precision medicine ecosystem and provides extensive insights of the different developments, trends and key participants. The report also focuses on different sub-markets which help in the development of precision medicine solutions. The sub-market verticals are categorized into five major categories, viz. companion diagnostics, biomarkers, targeted therapeutics, Pharmacogenomics and molecular diagnostics among others in the report.

The scope of this report is related to a detailed study of the solutions associated with Precision Medicine in the market. The study includes an analysis of therapeutics and applications in which precision medicine is used. In addition to this the market study also includes the ecosystem and geographical analysis. The study presents a detailed analysis of the precision medicine ecosystem, therapeutics, applications, and geography along these lines: market size, key participants, drivers, growth opportunities, and challenges.

The major end-use application areas of precision medicine with respect to the market size and growth rate has also been identified and discussed in the report. The advancement and innovation of new healthcare technologies are developing the platform for the growth of precision medicine market. Since, the announcement of Precision Medicine Initiative' by the President Barack Obama in January, 2015, a large number of research and development has been taken for the development of precise drugs, targeted therapeutics, and laboratory tests. Presently, the main focus of the government initiatives is toward oncology, but it is anticipated to target almost all therapeutic areas affected by genetic mutations.

Governmental regulations and standards are sustaining the growth and development of the precision medicine market. The main aim of these regulations is to make precision medicines more adaptable and focused towards genetic diseases related to Oncology, skin, respiratory, CNS, CVD, and infectious diseases among others. The patients are benefitted indirectly by these regulations as it save time and cut-down cost as the patients get the required treatment for the specific disease.

The growth in the precision medicine market is propelled by an increasing demand for personalized treatment, technological innovation and advancement (including Biomarker-based tests/kits, next gene sequencing, and precise imaging), Government support and regulations, and these have created a demand for the precision medicine solutions.

Key Topics Covered:

Executive Summary

1. Research Scope and Methodology

2. Market Overview

3. Market Dynamics

4 Competitive Landscape

5 Industry Insights

• Patent Landscape
• Consortiums, Associations and Regulatory Bodies

6 Global Precision Medicine Market by Technology Type, 2017-2026 ($Million)

• Big Data Analytics
• Bioinformatics
• Gene Sequencing
• Pharmacogenomics
• Companion Diagnostics
• Others

7 Global Precision Medicine Market by Application, 2017-2026 ($Million)

• Oncology
• Immunology
• Neurology
• Cardiology
• Infectious Disease
• Respiratory Medicines
• Others

8 Global Precision Medicine Market by End User, 2017-2026 ($Million)

• Pharmaceutical and Biotechnology Companies
• Clinical Laboratories
• Diagnostic Tool Companies
• Healthcare IT/Big Data Companies
• Others

9 Global Precision Medicine Market by Region, 2017-2026 ($Million)

10 Company Profiles

• Abbott Laboratories
• Amgen, Inc.
• Astellas Pharma
• AstraZeneca
• bioMerieux SA
• Bristol-Myers Squibb
• Eli Lilly and Company
• Epic Sciences
• F Hoffmann-La Roche AG
• GSK
• Gilead Sciences
• Illumina, Inc.
• Janssen Diagnostics
• Novartis AG
• Pfizer
• Precision For Medicines
• QIAGEN
• Teva Pharmaceutical
• Thermo Fisher Scientific, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/qrzt3h/global_precision

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets